Correlation Between Sunshine Biopharma and Evoke Pharma
Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Evoke Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Evoke Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunshine Biopharma and Evoke Pharma, you can compare the effects of market volatilities on Sunshine Biopharma and Evoke Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Evoke Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Evoke Pharma.
Diversification Opportunities for Sunshine Biopharma and Evoke Pharma
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Sunshine and Evoke is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma and Evoke Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evoke Pharma and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma are associated (or correlated) with Evoke Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evoke Pharma has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Evoke Pharma go up and down completely randomly.
Pair Corralation between Sunshine Biopharma and Evoke Pharma
Given the investment horizon of 90 days Sunshine Biopharma is expected to generate 1.59 times more return on investment than Evoke Pharma. However, Sunshine Biopharma is 1.59 times more volatile than Evoke Pharma. It trades about 0.04 of its potential returns per unit of risk. Evoke Pharma is currently generating about -0.27 per unit of risk. If you would invest 282.00 in Sunshine Biopharma on September 1, 2024 and sell it today you would earn a total of 4.00 from holding Sunshine Biopharma or generate 1.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sunshine Biopharma vs. Evoke Pharma
Performance |
| Timeline |
| Sunshine Biopharma |
| Evoke Pharma |
Sunshine Biopharma and Evoke Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sunshine Biopharma and Evoke Pharma
The main advantage of trading using opposite Sunshine Biopharma and Evoke Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Evoke Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evoke Pharma will offset losses from the drop in Evoke Pharma's long position.| Sunshine Biopharma vs. Tff Pharmaceuticals | Sunshine Biopharma vs. Eliem Therapeutics | Sunshine Biopharma vs. Inhibrx | Sunshine Biopharma vs. Enliven Therapeutics |
| Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |